SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,570.35 -373.93
( -0.49%)

Global Indices

Nasdaq

52,794.59 -412.31
(-0.77%)

Dow Jones

7,653.60 -53.54
(-0.69%)

Hang Seng

64,415.54 -1,799.80
(-2.72%)

Nikkei 225

10,761.93 -27.35
(-0.25%)

Forex

USD-INR

95.24 -0.24
(-0.25%)

EUR-INR

110.49 -0.08
(-0.07%)

GBP-INR

128.99 -0.20
(-0.15%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

356.2353295

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

52.37

9432.96

EPS(TTM)

Face Value()

Div & Yield %

19.54

0.49

Back

epigral ltd

Mahanagar Telephone Nigam reports consolidated net loss of Rs 842.36 crore in the June 2026 quarter

Aug 13,2026

Net Loss of Mahanagar Telephone Nigam reported to Rs 842.36 crore in the quarter ended June 2026 as against net loss of Rs 943.15 crore during the previous quarter ended June 2025. Sales rose 25.94% to Rs 216.89 crore in the quarter ended June 2026 as against Rs 172.22 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	216.89	172.22	26
OPM %	-15.22	-45.89	-
PBDT	-705.08	-797.98	12
PBT	-842.36	-943.15	11
NP	-842.36	-943.15	11

76,570.35 -373.93 ( -0.49%)

52,794.59 -412.31 (-0.77%)

7,653.60 -53.54 (-0.69%)

64,415.54 -1,799.80 (-2.72%)

10,761.93 -27.35 (-0.25%)

95.24 -0.24 (-0.25%)

110.49 -0.08 (-0.07%)

128.99 -0.20 (-0.15%)

0.60 0.00 (-0.03%)